image
Axsome Therapeutics, Inc. AXSM
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 127.54
0.894 %
$ 6.22 B
Market Cap
-21.26
P/E
INCOME STATEMENT
386 M REVENUE
42.53%
Growth Rates
1Year 42.53%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-281 M OPERATING INCOME
-21.02%
Growth Rates
1Year -21.02%
3Years -31.03%
5Years -33.07%
7Years -39.59%
10Years -47.72%
-287 M NET INCOME
-20.05%
Growth Rates
1Year -20.05%
3Years -30.11%
5Years -33.26%
7Years -38.80%
10Years -47.23%
EFFICIENCY
Earnings Waterfall Axsome Therapeutics, Inc.
image
Revenue 386 M
Cost Of Revenue 33.3 M
Gross Profit 352 M
Operating Expenses 633 M
Operating Income -281 M
Other Expenses 6.65 M
Net Income -287 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 385.7 270.6 50.0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 33.3 26.1 5.2 1.2 77.7 K 37.3 K 48.9 K 42.6 K 20.5 K 3.54 K 0 0
Gross Profit 352.4 244.5 44.8 (1.2) 77.7 K 37.3 K 48.9 K 42.6 K 20.5 K 3.54 K 0 0
OPERATING INCOME
Operating Expenses 633.0 476.4 221.3 124.7 99.1 67.1 32.6 27.0 27.1 9.2 5.5 1.8
Selling, General and Administrative Expenses 411.4 323.1 159.3 66.6 28.9 13.6 9.4 7.2 6.3 2.4 1.4 0.3
Research and Development Expenses 187.1 97.9 57.9 58.1 70.2 53.6 23.5 20.0 21.2 6.8 4.3 1.5
Operating Income (280.6) (231.8) (176.5) (124.7) (99.1) (67.2) (32.8) (27.2) (27.5) (9.2) (5.7) (1.8)
PRE-TAX INCOME
Interest Income Expense 6.6 6.5 7.3 5.7 2.6 1.2 1.1 1.3 0.1 0.9 2.2 0.3
Total Other Income (6.6) (6.5) (7.3) (5.7) (3.8) (1.2) 1.7 (1.8) 0.3 (1.4) (0.3) (0.3)
Pre-Tax Income (287.1) (238.3) (187.1) (130.4) (102.9) (68.3) (31.0) (28.9) (27.2) (10.6) (6.0) (2.2)
NET INCOME
Tax Provision 85 K 1.0 10.6 4.5 2.5 1.3 3.0 1.3 0.6 1.4 (2.4) (1.8)
Net Income (287.2) (239.2) (197.8) (134.9) (105.4) (69.7) (31.0) (28.9) (27.2) (10.6) (6.0) (2.2)
EPS 5.99 5.27 4.86 3.59 2.83 2.05 1.15 1.27 1.42 0.88 0.47 0.17